<DOC>
	<DOCNO>NCT00882739</DOCNO>
	<brief_summary>The aim study determine safety effectiveness three different load dose regimen clopidogrel patient acute myocardial infarction undergo primary angioplasty .</brief_summary>
	<brief_title>Safety Efficacy Three Different Loading Doses Clopidogrel , Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description>This study enroll STEMI patient , plan undergo PCI , randomize three different clopidogrel load dose regimen first medical contact : pre-treatment , 600 mg 900 mg. Platelet activity administration clopidogrel evaluate VerifyNowâ„¢ P2Y12 point-of-care system . The study power demonstrate significant difference primary end point ( rate TIMI Myocardial Perfusion Grade=3 ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>STelevation myocardial infarction : chest pain last 30 minute responsive nitrate STsegment elevation 0.1 mV two lead ECG , new Left Bundle Branch Block With indication primary PCI , present within 12 hour symptom onset Age &gt; 18 year Planned PCI Informed Consent bleed diathesis allergy study drug pregnancy performance rescue PCI thrombolysis know existence disease result life expectancy &lt; 6 month lack informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>angiography</keyword>
	<keyword>percutaneous coronary intervention</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Platelet Function Tests</keyword>
</DOC>